Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.

Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian A, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2012 Jun;18(6):716-26. doi: 10.1002/lt.23411.

2.

Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.

Locke JE, Durand C, Reed RD, MacLennan PA, Mehta S, Massie A, Nellore A, DuBay D, Segev DL.

Transplantation. 2016 Jan;100(1):141-6. doi: 10.1097/TP.0000000000000829.

3.

A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.

Locke JE, Mehta S, Reed RD, MacLennan P, Massie A, Nellore A, Durand C, Segev DL.

J Am Soc Nephrol. 2015 Sep;26(9):2222-9. doi: 10.1681/ASN.2014070726. Epub 2015 Mar 19.

4.

Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.

Sawinski D, Goldberg DS, Blumberg E, Abt PL, Bloom RD, Forde KA.

Clin Infect Dis. 2015 Oct 1;61(7):1054-62. doi: 10.1093/cid/civ471. Epub 2015 Jun 16.

5.

Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.

Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Rajender Reddy K; Solid Organ Transplantation in HIV: Multi-Site Study Investigators.

Liver Transpl. 2013 Jun;19(6):619-26. doi: 10.1002/lt.23648.

6.

Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.

Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P; HIVTR Investigators.

Am J Transplant. 2014 May;14(5):1129-35. doi: 10.1111/ajt.12668. Epub 2014 Mar 17.

7.

Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.

Hung K, Gralla J, Dodge JL, Bambha KM, Dirchwolf M, Rosen HR, Biggins SW.

Liver Transpl. 2015 Nov;21(11):1365-73. doi: 10.1002/lt.24138.

8.

Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.

Baccarani U, Adani GL, Bragantini F, Londero A, Comuzzi C, Rossetto A, Lorenzin D, Bresadola V, Risaliti A, Pea F, Toniutto P, Donini A, De Anna D, Bresadola F, Tavio M, Viale P.

Transplant Proc. 2011 May;43(4):1119-22. doi: 10.1016/j.transproceed.2011.01.124.

PMID:
21620067
9.

Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.

Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS Jr, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK, Everhart JE, Rodrigo del R; A2ALL Study Group.

Hepatology. 2014 Apr;59(4):1311-9. doi: 10.1002/hep.26920. Epub 2014 Mar 1.

10.

Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(4):1-56. Epub 2010 Mar 1.

11.

Immunologic Predictors of Liver Transplantation Outcomes in HIV-HCV Co-Infected Persons.

Balagopal A, Barin B, Quinn J, Rogers R, Sulkowski MS, Stock PG.

PLoS One. 2015 Aug 27;10(8):e0135882. doi: 10.1371/journal.pone.0135882. eCollection 2015.

12.

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Lo Re V 3rd, Volk J, Newcomb CW, Yang YX, Freeman CP, Hennessy S, Kostman JR, Tebas P, Leonard MB, Localio AR.

Hepatology. 2012 Nov;56(5):1688-98. doi: 10.1002/hep.25866. Epub 2012 Oct 14.

13.

Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.

Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.

Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030.

PMID:
19376421
14.

Is liver transplantation feasible in patients coinfected with human immunodeficiency virus and hepatitis C virus?

Baccarani U, Scudeller L, Adani GL, Viale P, Tavio M.

Liver Transpl. 2012 Jun;18(6):744-5; author reply 746. doi: 10.1002/lt.23419. No abstract available.

15.

Liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected patients: response needed!

O'Grady JG.

Liver Transpl. 2012 Jun;18(6):617-8. doi: 10.1002/lt.23431. No abstract available.

16.

Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.

Waki K, Sugawara Y, Tamura S, Mieno MN, Yamashiki N, Kadowaki T, Kokudo N.

Transplantation. 2011 Oct 15;92(7):809-14. doi: 10.1097/TP.0b013e31822d4dc3.

PMID:
21832961
17.

The corrected donor age for hepatitis C virus-infected liver transplant recipients.

Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW.

Liver Transpl. 2015 Aug;21(8):1022-30. doi: 10.1002/lt.24194.

18.

Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C.

Hibi T, Nishida S, Sageshima J, Levi DM, Ruiz P, Roth D, Martin P, Okabayashi K, Burke GW, Ciancio G, Tzakis AG.

Transpl Int. 2014 Jun;27(6):606-16. doi: 10.1111/tri.12303. Epub 2014 Mar 31.

19.

Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.

Castells L, Rimola A, Manzardo C, Valdivieso A, Montero JL, Barcena R, Abradelo M, Xiol X, Aguilera V, Salcedo M, Rodriguez M, Bernal C, Suarez F, Antela A, Olivares S, Del Campo S, Laguno M, Fernandez JR, de la Rosa G, Agüero F, Perez I, González-García J, Esteban-Mur JI, Miro JM; FIPSE LT-HIV Investigators.

J Hepatol. 2015 Jan;62(1):92-100. doi: 10.1016/j.jhep.2014.07.034. Epub 2014 Aug 13. Erratum in: J Hepatol. 2016 Mar;64(3):757.

PMID:
25127748
20.

The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.

Pang PS, Kamal A, Glenn JS.

Liver Transpl. 2009 Sep;15(9):1126-32. doi: 10.1002/lt.21835.

Supplemental Content

Support Center